Gerresheimer well-positioned for further growth

Düsseldorf (ots) -

* Financial year 2009 successfully completed
* Good start to the year 2010 * Confirmation of guidance of 2% to
4% sales growth for 2010 with an operating margin of around
19.5%

At today's Annual General Meeting of Gerresheimer AG wide approval
was given by shareholders on all the agenda items. The CEO Dr. Axel
Herberg commented on the starting position for 2010: "We have ended
the financial year 2009 with very solid figures and have made a good
start to the year 2010. Gerresheimer is ideally positioned to
continue on the path of success." In his speech the CEO confirmed the
guidance for the current financial year with sales growth of 2% to 4%
and an improvement in the operating margin (adjusted EBITDA margin)
to around 19.5%.

At today's meeting Dr. Axel Herberg, who is going to leave the
Management Board on June 21, 2010, was elected by a large majority to
the Supervisory Board with effect from September 1, 2010. His
successor as CEO is going to be Uwe Röhrhoff, the Management Board
member of many years standing.

The Annual General Meeting followed the management's proposal to
waive the payment of a dividend. The funds will instead be used for
further debt reduction and exploitation of growth opportunities.

In detail the Annual General Meeting - with 63.32 percent of the
capital stock represented - passed the following resolutions:

ITEM 2: Appropriation of net earnings for the financial year 2009:
carry forward in total to the new account.
(99.24 percent of votes in favor)

ITEM 3: Formal approval of the actions of the members of the
Management Board for the financial year 2009:
(93.93 percent of votes in favor)

ITEM 4: Formal approval of the actions of the members of the
Supervisory Board for the financial year 2009:
(93.91 percent of votes in favor)

ITEM 5: Election of the auditor for the financial year 2010:
(100.0 percent of votes in favor)

ITEM 6: Supplementary election of Dr. Axel Herberg to the
Supervisory Board:
(94.76 percent of votes in favor)

ITEM 7: Amendments to the Articles of Association because of the
German Act to Implement the Shareholder Rights Directive
(ARUG):
(90.79 percent of votes in favor)
Amendments to the Articles of Association on Supervisory
Board remuneration:
(90.78 percent of votes in favor)

ITEM 8: Approval of the system for remuneration of Management
Board members
(63.72 percent of votes in favor)

The speech of the CEO to the Annual General Meeting can be found
under http://www.gerresheimer.de/en/investor-relations/annual-general
-meeting/2010.html .

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of
high-quality specialty products made of glass and plastic for the
global pharma & healthcare industry. Our wide product spectrum ranges
from pharmaceutical vials to complex drug delivery systems, such as
syringe systems, insulin pens and inhalers, for safe dosage and
application. Together with our partners we develop solutions which
set standards and have role-model status throughout their respective
business sectors.

Our Group of companies achieves in Europe, North and South America
and Asia sales of about ?1 billion and employs around 9,400 people.
Through top-class technologies, convincing innovations and targeted
investments we are systematically expanding our strong market
position.

Originaltext: Gerresheimer AG
digital press kits: http://www.presseportal.de/pm/9072
press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6

Contact:
Press Contact
Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-mail b.lingenberg@gerresheimer.com

Investor Relations Contact
Anke Linnartz
Director Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
E-mail: a.linnartz@gerresheimer.com